Fluconazole Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-R-0009

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Logistics Agency (DLA) Troop Support, a federal office responsible for supplying critical materials to military and government operations, has issued Solicitation SPE2D2-25-R-0009 for the procurement of Fluconazole Tablets. This solicitation falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on drugs and biologicals. The primary objective of this procurement is to secure a reliable supply of Fluconazole Tablets, an essential antifungal medication, to support the health and readiness of military personnel and other federal beneficiaries. The scope of the contract encompasses the manufacturing and timely delivery of pharmaceutical-grade Fluconazole Tablets, adhering to all applicable regulatory standards and quality requirements as specified in the solicitation documents. Amendment 0004 has been issued, extending the solicitation period to July 8, 2025, thereby providing additional time for interested vendors to prepare and submit comprehensive proposals. The solicitation remains active, with a response deadline set for August 7, 2025. Key requirements for this opportunity include demonstrated capability in pharmaceutical manufacturing, compliance with federal quality and safety standards, and the ability to meet the delivery schedules outlined by DLA Troop Support. Offerors are expected to provide detailed information regarding their manufacturing processes, quality assurance protocols, and past performance in supplying similar pharmaceutical products. The contracting activity is managed by DLA Troop Support, with primary and secondary points of contact available for inquiries: Courtney Hunter-Stangler ([email protected]) and Catherine Gilbert ([email protected], phone: 445-737-8868). Interested parties are encouraged to review the six attachments available via the official SAM.gov opportunity listing for comprehensive solicitation details and submission instructions. This procurement is a solicitation, and any set-aside requirements or special considerations are not specified in the provided information. Contractors with proven experience in pharmaceutical preparation manufacturing and the capacity to fulfill federal supply contracts are encouraged to evaluate this opportunity for alignment with their capabilities and strategic objectives. For further information and to access the solicitation documents, please refer to the official notice at: https://sam.gov/opp/0f2e73a5cfbc489ba9f695ea8e3b5382/view.
Documents6